Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 15;12(2):42-84.
eCollection 2023.

Neurological manifestation in COVID-19 disease with neuroimaging studies

Sadegh Ghaderi  1 , Mahsa Olfati  2 , Majid Ghaderi  3 , Hojatollah Hadizadeh  2 , Ghazal Yazdanpanah  4 , Zahra Khodadadi  5 , Asra Karami  6 , Zahra Papi  7 , Negar Abdi  8 , Seyedeh Shadi Sharif Jalali  9 , Rahim Khatyal  10 , Shabnam Banisharif  7 , Fatemeh Bahari  11 , Marziyeh Zarasvandnia  12 , Sana Mohammadi  13 , Mahdi Mohammadi  14
Affiliations
Review

Neurological manifestation in COVID-19 disease with neuroimaging studies

Sadegh Ghaderi et al. Am J Neurodegener Dis. .

Abstract

Objective: Magnetic resonance imaging (MRI) of the brain or spine examines the findings as well as the time interval between the onset of symptoms and other adverse effects in coronavirus disease that first appeared in 2019 (COVID-19) patients. The goal of this study is to look at studies that use neuroimaging to look at neurological and neuroradiological symptoms in COVID-19 patients.

Methods: We try to put together all of the research on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes neurological symptoms and cognitive-behavioral changes and give a full picture.

Results: We have categorized neuroimaging findings into subtitles such as: headache and dizziness; cerebrovascular complications after stroke; Intracerebral Hemorrhage (ICH); Cerebral Microbleeds (CMBs); encephalopathy; meningitis; encephalitis and myelitis; altered mental status (AMS) and delirium; seizure; neuropsychiatric symptoms; Guillain-Barre Syndrome (GBS) and its variants; smell and taste disorders; peripheral neuropathy; Mild Cognitive Impairment (MCI); and myopathy and myositis.

Conclusion: In this review study, we talked about some MRI findings that show how COVID-19 affects the nervous system based on what we found.

Keywords: COVID-19; cognitive-behavioral disorders; magnetic resonance imaging; neurological symptoms; neuropsychological symptoms.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Inclusion and exclusion criteria of the study.
Figure 2
Figure 2
Neuroimaging techniques and common neurological manifestations in COVID-19.
See this image and copyright information in PMC

References

    1. Maghsoudinia F, Tavakoli MB, Samani RK, Hejazi SH, Sobhani T, Mehradnia F, Mehrgardi MA. Folic acid-functionalized gadolinium-loaded phase transition nanodroplets for dual-modal ultrasound/magnetic resonance imaging of hepatocellular carcinoma. Talanta. 2021;228:122245. - PubMed
    1. Ansari L, Sharifi I, Ghadrijan H, Azarpira N, Momeni F, Zamani H, Rasouli N, Mohammadi M, Mehdizadeh A, Abedi-Firouzjah R. Synthesis, characterization and MRI application of cobalt-zinc ferrite nanoparticles coated with DMSA: an in-vivo study. Appl Magn Reson. 2021;52:33–45.
    1. Ghaderi S, Divband B, Gharehaghaji N. Magnetic resonance imaging property of doxorubicin-loaded gadolinium/13X zeolite/folic acid nanocomposite. J Biomed Phys Eng. 2020;10:103–110. - PMC - PubMed
    1. Ghaderi S, Ghaderi K, Ghaznavi H. Using marker-controlled watershed transform to detect Baker’s cyst in magnetic resonance imaging images: a pilot study. J Med Signals Sens. 2022;12:84–89. - PMC - PubMed
    1. Kremer S, Lersy F, Anheim M, Merdji H, Schenck M, Oesterlé H, Bolognini F, Messie J, Khalil A, Gaudemer A, Carré S, Alleg M, Lecocq C, Schmitt E, Anxionnat R, Zhu F, Jager L, Nesser P, Mba YT, Hmeydia G, Benzakoun J, Oppenheim C, Ferré JC, Maamar A, Carsin-Nicol B, Comby PO, Ricolfi F, Thouant P, Boutet C, Fabre X, Forestier G, de Beaurepaire I, Bornet G, Desal H, Boulouis G, Berge J, Kazémi A, Pyatigorskaya N, Lecler A, Saleme S, Edjlali-Goujon M, Kerleroux B, Constans JM, Zorn PE, Mathieu M, Baloglu S, Ardellier FD, Willaume T, Brisset JC, Caillard S, Collange O, Mertes PM, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, Meyer N, Helms J, Cotton F. Neurologic and neuroimaging findings in patients with COVID-19: a retrospective multicenter study. Neurology. 2020;95:e1868–e1882. - PubMed

LinkOut - more resources